GlassScriptPhysician profile
Wesley A Porta
NPI 1508180530
$4,436.35
in general payments reported to CMS, 2019-2025
39 companies · $918 in 2025
The $918 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $553 · 2020: $299 · 2021: $386 · 2022: $448 · 2023: $912 · 2024: $921 · 2025: $918.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,750.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $629.77 | 2023-2025 | Gemtesa |
| Neotract INC. | $450.75 | 2019-2020 | |
| Procept Biorobotics Corporation | $361.71 | 2022-2025 | Aquabeam System |
| Antares Pharma, INC. | $345.59 | 2024-2025 | Xyosted |
| Astellas Pharma US INC | $321.96 | 2019-2025 | Xtandi, Myrbetriq |
| Teleflex LLC | $316.26 | 2023-2024 | Urolift |
| Boston Scientific Corporation | $301.23 | 2019-2024 | Rezum Generator |
| Abbvie INC. | $221.42 | 2019-2025 | |
| Coloplast Corp | $170.99 | 2021-2025 | |
| Urogen Pharma, INC. | $158.07 | 2022-2025 | Jelmyto |
| Medtronic, INC. | $124.61 | 2023-2025 | Interstim |
| Progenics Pharmaceuticals, INC. | $116.19 | 2021-2023 | Pylarify |
| Olympus America INC. | $100.07 | 2023-2025 | Itind System |
| Endo Pharmaceuticals INC. | $95.73 | 2020-2022 | |
| Hollister Incorporated | $58.05 | 2021-2024 | Infyna Chic |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Steris Corporation | $54.05 | 2025 | |
| Stryker Corporation | $41.99 | 2025 | 1788, Spy-Phi System |
| Medtronic USA, INC. | $40.53 | 2019 | |
| Allergan, INC. | $40.10 | 2019-2021 | |
| Abc Home Medical Supply, INC. | $37.50 | 2024 | |
| Blue Earth Diagnostics | $37.28 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $36.21 | 2024-2025 | Adstiladrin |
| Rochester Medical Corporation | $34.20 | 2022 | |
| Urovant Sciences INC | $33.40 | 2022 | |
| Dendreon Pharmaceuticals LLC | $32.68 | 2025 | Provenge |
| Accord Healthcare, INC. | $29.04 | 2024 | |
| Janssen Biotech, INC. | $25.19 | 2025 | Erleada |
| Endo USA, INC. | $24.81 | 2024 | Xiaflex, Aveed |
| Merck Sharp & Dohme LLC | $23.09 | 2021 | |
| Amag Pharmaceuticals, INC. | $21.21 | 2019 | |
| Convatec INC. | $21.11 | 2022 | |
| Tolmar, INC. | $19.18 | 2024 | |
| Cycle Pharmaceuticals INC | $18.06 | 2025 | Venxxiva |
| Civco Medical Instruments | $18.01 | 2025 | |
| Mission Pharmacal Company | $17.50 | 2024 | Uribel Tabs |
| Therapeuticsmd, INC. | $16.42 | 2019 | |
| Photocure INC | $14.25 | 2025 | Cysview |
| Pacira Pharmaceuticals Incorporated | $14.08 | 2019 | |
| Pfizer INC. | $14.06 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Porta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.